139 related articles for article (PubMed ID: 26891146)
21. BNC105: a novel tubulin polymerization inhibitor that selectively disrupts tumor vasculature and displays single-agent antitumor efficacy.
Kremmidiotis G; Leske AF; Lavranos TC; Beaumont D; Gasic J; Hall A; O'Callaghan M; Matthews CA; Flynn B
Mol Cancer Ther; 2010 Jun; 9(6):1562-73. PubMed ID: 20515948
[TBL] [Abstract][Full Text] [Related]
22. MEKK1 is essential for DT40 cell apoptosis in response to microtubule disruption.
Kwan R; Burnside J; Kurosaki T; Cheng G
Mol Cell Biol; 2001 Nov; 21(21):7183-90. PubMed ID: 11585901
[TBL] [Abstract][Full Text] [Related]
23. Microtubule inhibitors elicit differential effects on MAP kinase (JNK, ERK, and p38) signaling pathways in human KB-3 carcinoma cells.
Stone AA; Chambers TC
Exp Cell Res; 2000 Jan; 254(1):110-9. PubMed ID: 10623471
[TBL] [Abstract][Full Text] [Related]
24. The newly synthesized 2-arylnaphthyridin-4-one, CSC-3436, induces apoptosis of non-small cell lung cancer cells by inhibiting tubulin dynamics and activating CDK1.
Chang LC; Yu YL; Liu CY; Cheng YY; Chou RH; Hsieh MT; Lin HY; Hung HY; Huang LJ; Wu YC; Kuo SC
Cancer Chemother Pharmacol; 2015 Jun; 75(6):1303-15. PubMed ID: 25947085
[TBL] [Abstract][Full Text] [Related]
25. Hyperforin induces apoptosis of chronic lymphocytic leukemia cells through upregulation of the BH3-only protein Noxa.
Zaher M; Tang R; Bombarda I; Merhi F; Bauvois B; Billard C
Int J Oncol; 2012 Jan; 40(1):269-76. PubMed ID: 21947285
[TBL] [Abstract][Full Text] [Related]
26. Unraveling the molecular mechanism of BNC105, a phase II clinical trial vascular disrupting agent, provides insights into drug design.
Wang T; Wu C; Wang C; Zhang G; Arnst KE; Yao Y; Zhang Z; Wang Y; Pu D; Li W
Biochem Biophys Res Commun; 2020 Feb; ():. PubMed ID: 32085900
[TBL] [Abstract][Full Text] [Related]
27. Inducer-and cell type-specific regulation of antiapoptotic MCL1 in myeloid leukemia and multiple myeloma cells exposed to differentiation-inducing or microtubule-disrupting agents.
Vrana JA; Cleaveland ES; Eastman A; Craig RW
Apoptosis; 2006 Aug; 11(8):1275-88. PubMed ID: 16761109
[TBL] [Abstract][Full Text] [Related]
28. Analysis of migratory and prosurvival pathways induced by the homeostatic chemokines CCL19 and CCL21 in B-cell chronic lymphocytic leukemia.
Cuesta-Mateos C; López-Giral S; Alfonso-Pérez M; de Soria VG; Loscertales J; Guasch-Vidal S; Beltrán AE; Zapata JM; Muñoz-Calleja C
Exp Hematol; 2010 Sep; 38(9):756-64, 764.e1-4. PubMed ID: 20488224
[TBL] [Abstract][Full Text] [Related]
29. 6α-Acetoxyanopterine: A Novel Structure Class of Mitotic Inhibitor Disrupting Microtubule Dynamics in Prostate Cancer Cells.
Levrier C; Sadowski MC; Rockstroh A; Gabrielli B; Kavallaris M; Lehman M; Davis RA; Nelson CC
Mol Cancer Ther; 2017 Jan; 16(1):3-15. PubMed ID: 27760837
[TBL] [Abstract][Full Text] [Related]
30. Vinca alkaloids cause aberrant ROS-mediated JNK activation, Mcl-1 downregulation, DNA damage, mitochondrial dysfunction, and apoptosis in lung adenocarcinoma cells.
Chiu WH; Luo SJ; Chen CL; Cheng JH; Hsieh CY; Wang CY; Huang WC; Su WC; Lin CF
Biochem Pharmacol; 2012 May; 83(9):1159-71. PubMed ID: 22285910
[TBL] [Abstract][Full Text] [Related]
31. XN05, a novel synthesized microtubule inhibitor, exhibits potent activity against human carcinoma cells in vitro.
Wu R; Ding W; Liu T; Zhu H; Hu Y; Yang B; He Q
Cancer Lett; 2009 Nov; 285(1):13-22. PubMed ID: 19647933
[TBL] [Abstract][Full Text] [Related]
32. Combretastatin-A4 prodrug induces mitotic catastrophe in chronic lymphocytic leukemia cell line independent of caspase activation and poly(ADP-ribose) polymerase cleavage.
Nabha SM; Mohammad RM; Dandashi MH; Coupaye-Gerard B; Aboukameel A; Pettit GR; Al-Katib AM
Clin Cancer Res; 2002 Aug; 8(8):2735-41. PubMed ID: 12171907
[TBL] [Abstract][Full Text] [Related]
33. Arsenic trioxide induces Noxa-dependent apoptosis in rhabdomyosarcoma cells and synergizes with antimicrotubule drugs.
Meister MT; Boedicker C; Graab U; Hugle M; Hahn H; Klingebiel T; Fulda S
Cancer Lett; 2016 Oct; 381(2):287-95. PubMed ID: 27521572
[TBL] [Abstract][Full Text] [Related]
34. Nocodazole, a microtubule de-polymerising agent, induces apoptosis of chronic lymphocytic leukaemia cells associated with changes in Bcl-2 phosphorylation and expression.
Beswick RW; Ambrose HE; Wagner SD
Leuk Res; 2006 Apr; 30(4):427-36. PubMed ID: 16162358
[TBL] [Abstract][Full Text] [Related]
35. The tubulin-depolymerising agent combretastatin-4 induces ectopic aster assembly and mitotic catastrophe in lung cancer cells H460.
Cenciarelli C; Tanzarella C; Vitale I; Pisano C; Crateri P; Meschini S; Arancia G; Antoccia A
Apoptosis; 2008 May; 13(5):659-69. PubMed ID: 18386182
[TBL] [Abstract][Full Text] [Related]
36. Characterization of vinblastine-induced Bcl-xL and Bcl-2 phosphorylation: evidence for a novel protein kinase and a coordinated phosphorylation/dephosphorylation cycle associated with apoptosis induction.
Du L; Lyle CS; Chambers TC
Oncogene; 2005 Jan; 24(1):107-17. PubMed ID: 15531923
[TBL] [Abstract][Full Text] [Related]
37. Sensitivity of docetaxel-resistant MCF-7 breast cancer cells to microtubule-destabilizing agents including vinca alkaloids and colchicine-site binding agents.
Wang RC; Chen X; Parissenti AM; Joy AA; Tuszynski J; Brindley DN; Wang Z
PLoS One; 2017; 12(8):e0182400. PubMed ID: 28787019
[TBL] [Abstract][Full Text] [Related]
38. The c-Jun NH(2)-terminal protein kinase/AP-1 pathway is required for efficient apoptosis induced by vinblastine.
Fan M; Goodwin ME; Birrer MJ; Chambers TC
Cancer Res; 2001 Jun; 61(11):4450-8. PubMed ID: 11389075
[TBL] [Abstract][Full Text] [Related]
39. Microtubule destabilising agents: far more than just antimitotic anticancer drugs.
Bates D; Eastman A
Br J Clin Pharmacol; 2017 Feb; 83(2):255-268. PubMed ID: 27620987
[TBL] [Abstract][Full Text] [Related]
40. Transcription factor NF-κB associates with microtubules and stimulates apoptosis in response to suppression of microtubule dynamics in MCF-7 cells.
Rai A; Kapoor S; Singh S; Chatterji BP; Panda D
Biochem Pharmacol; 2015 Feb; 93(3):277-89. PubMed ID: 25536174
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]